Target intelligence / Profile preview

Clostridium perfringens alpha toxin (CPA)

Target
CPA
Molecular classification
Bacterial toxin, Enzyme, Metallophospholipase, Phospholipase C-type enzyme
01

Overview

Clostridium perfringens alpha toxin is a zinc-dependent metalloenzyme and the primary virulence factor produced by C. perfringens, responsible for gas gangrene and myonecrosis in humans and animals. It possesses dual enzymatic activity as a phospholipase C and sphingomyelinase, targeting and hydrolyzing membrane phospholipids such as phosphatidylcholine and sphingomyelin, which leads to cell membrane destruction, lysis, and cytotoxicity. The toxin also induces secondary messenger cascades, stimulates platelet aggregation, increases vascular permeability, and is uniquely associated with hemolytic activity, tissue necrosis, and lethal infections. As a secreted protein of about 370 amino acids, its structure includes an N-terminal catalytic domain and a C-terminal calcium-binding domain that facilitate membrane binding and enzymatic action. Alpha toxin is a key target for vaccine and antitoxin development, but clinical therapy remains mostly supportive, with experimental work on inhibitors and neutralizing antibodies ongoing.

Other names
Alpha toxinCPAphospholipase C (PLC) [within this context]Clostridium welchii alpha toxinzinc-dependent phospholipase C
02

Mechanism of action

Hydrolyzes phosphatidylcholine and sphingomyelin in cell membranes (via phospholipase C and sphingomyelinase activity), causing membrane disruption and cell death; Induces production of diacylglycerol and ceramide, activating secondary messenger pathways in host cells that cause inflammation and vascular effects

03

Biological functions

Membrane hydrolysisCytotoxicityHemolysisInduction of cell lysisPlatelet aggregationIncrease of vascular permeabilityActivation of host signaling pathways
04

Disease associations

InfectionGas gangrene (clostridial myonecrosis)SepsisEnteritisSkin necrosis
05

Safety considerations

High lethality and dermonecrotic effects (tissue destruction)Induction of severe inflammatory responsesHemolytic activity and vascular damageChallenges in neutralizing activity in established infections
06

Interacting drugs

Antitoxins (antibody-based or vaccine-derived)

2 more in the full profile.

07

Biomarkers

Detection of alpha toxin activity in tissue or blood as a diagnostic biomarker for gas gangrene or invasive C. perfringens infection

Beyond the preview

Go deeper on Clostridium perfringens alpha toxin (CPA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clostridium perfringens alpha toxin (CPA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call